AFC Gamma (0FG) Stock Price & Analysis
0FG Stock Chart & Stats
- Day’s Range
- EUR 2.63 - EUR 2.64
- 52-Week Range
- EUR 1.74 - EUR 3.17
- Previous Close
- EUR 2.64
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 60.56M
- Enterprise Value
- EUR 171.98M
- Total Cash (Recent Filing)
- EUR 106.51M
- Total Debt (Recent Filing)
- EUR 206.58M
- Price to Earnings (P/E)
- 15.8
- Beta
- 0.74
- Next Earnings
- Nov 05, 2026 (Est.)
- EPS Estimate
- 0.15
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 4.98%
Bulls Say, Bears Say
Bulls Say
Senior-secured Portfolio
The first-lien structure gives AFCG priority claims on collateral, while the 13.2% weighted-average yield supports recurring interest income. This combination can protect recoveries and sustain earnings power as the portfolio is managed and legacy exposures are resolved.
Liquidity And Deployment Capacity
Substantial liquidity and a broad underwriting pipeline give AFCG capacity to originate new loans without relying immediately on external capital. Continued deployment into targeted lower-middle-market opportunities could diversify earnings and improve portfolio scale over the next several quarters.
Diversification Beyond Cannabis
The behavioral-health commitment demonstrates a tangible move into non-cannabis lending rather than relying solely on the legacy cannabis book. Broader sector exposure may reduce concentration risk and create a more durable base of senior-secured interest income over time.
Bears Say
Negative Cash Generation
Negative operating and free cash flow weaken the connection between reported earnings and internally generated funding. If the cash deficit persists, AFCG may need additional borrowing, asset repayments, or capital actions to support new originations and maintain financial flexibility.
Legacy Cannabis Credit Losses
Concentrated non-accruals and an active foreclosure can reduce interest income while creating uncertainty around collateral recoveries. Even with progress on other resolutions, continued legacy workout activity could absorb management attention and weigh on portfolio value and earnings consistency.
Lumpy Origination Growth
Uneven origination volume makes portfolio growth and interest revenue less predictable. A quarter with repayments exceeding new funding can shrink earning assets, while irregular deal timing may leave liquidity underdeployed and make quarter-to-quarter results dependent on episodic transactions.
AFC Gamma News
0FG FAQ
What was AFC Gamma’s price range in the past 12 months?
What is AFC Gamma’s market cap?
When is AFC Gamma’s upcoming earnings report date?
How were AFC Gamma’s earnings last quarter?
Is AFC Gamma overvalued?
Does AFC Gamma pay dividends?
What is AFC Gamma’s EPS estimate?
How many shares outstanding does AFC Gamma have?
What happened to AFC Gamma’s price movement after its last earnings report?
Which hedge fund is a major shareholder of AFC Gamma?
What is the TipRanks Smart Score and how is it calculated?
AFC Gamma Stock Smart Score
Company Description
AFC Gamma
Advanced Flower Capital Inc. originates, structures, underwrites, invests in, and manages senior secured loans and other types of mortgage loans and debt securities for established companies operating in the cannabis industry. It primarily originates loans structured as senior loans secured by real estate, equipment, cash flows, and licenses and/or other assets of the loan parties to the extent permitted by applicable laws and the regulations governing such loan parties. The company was formerly known as AFC Gamma, Inc. and changed its name to Advanced Flower Capital Inc. in October 2024. Advanced Flower Capital Inc. was incorporated in 2020 and is based in West Palm Beach, Florida.
- Sector
- Financial
- Industry
- Asset Management
- CEO
- Daniel Neville
- Employees
- 26
- Website
- advancedflowercapital.com
- Address
- 477 S. Rosemary Avenue, West Palm Beach, FL, 33401, US
AFC Gamma (0FG) Earnings & Revenues
0FG Company Deck
0FG Earnings Call
Earnings Call SentimentPositive
The call conveyed constructive operational progress: NAV increased, share repurchases were accretive, portfolio yield remains attractive (13.2%), liquidity is ample (~$106.5M cash and >$70M deployable), and the company is actively redeploying into non-cannabis lower middle market opportunities (1.3B pipeline). Offsetting these positives are concentrated legacy cannabis non-accruals (including an active default and foreclosure), a quarter-over-quarter dip in reported investment income due to Q1 episodic exit fees, and originations that were lumpy and slower in Q2. Management has made tangible progress on legacy recoveries (Devi and DMA) and improved post-quarter leverage via revolver repayments, which supports a cautiously optimistic outlook.
View all DE:0FG earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 6 | 12 |
| Technical Analysis | 2 | 6 | 2 |
| Moving Averages | 2 | 0 | 10 |
